THOUSAND OAKS, Calif., Dec. 8, 2010 /PRNewswire via COMTEX/ --
Amgen (Nasdaq: AMGN) will participate in Deutsche Bank's 2010 BioFEST on Wednesday, Dec. 15, 2010, at the Four Seasons in Boston, beginning at 10:00 a.m. Eastern Time. Roy Baynes, M.D., Ph.D., vice president of Global Development and Arvind Sood, vice president, Investor Relations will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
|
CONTACT: Amgen, Thousand Oaks |
|
|
David Polk, 805-447-4613 (media) |
|
|
John Shutter, 805-447-1060 (investors) |
|
(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)
SOURCE Amgen